Download
https://www.ndtvprofit.com/business/strides-pharma-arms-gets-us-fda-approval-for-potassium-deficiency-drug?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
The company also has a pipeline of other potassium chloride products, which are expected to be approved and launched in FY24.
Share